These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34536973)

  • 41. Cd36 gene expression in adipose and hepatic tissue mediates the lipids accumulation in liver of obese rats with sucrose-induced hepatic steatosis.
    Quintana-Castro R; Aguirre-Maldonado I; Soto-Rodríguez I; Deschamps-Lago RA; Gruber-Pagola P; Urbina de Larrea YK; Juárez-Rivera VE; Ramos-Manuel LE; Alexander-Aguilera A
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106404. PubMed ID: 31838198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway.
    Yu H; Yang F; Zhong W; Jiang X; Zhang F; Ji X; Xue M; Qiu Y; Yu J; Hu X; Chen J; Bao Z
    Cell Signal; 2021 Aug; 84():110043. PubMed ID: 33991615
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Bae S; Lee YH; Lee J; Park J; Jun W
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558538
    [No Abstract]   [Full Text] [Related]  

  • 44. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease.
    Qiao JT; Cui C; Qing L; Wang LS; He TY; Yan F; Liu FQ; Shen YH; Hou XG; Chen L
    Metabolism; 2018 Apr; 81():13-24. PubMed ID: 29106945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic DKK1-driven steatosis is CD36 dependent.
    Yang Z; Huang X; Zhang J; You K; Xiong Y; Fang J; Getachew A; Cheng Z; Yu X; Wang Y; Wu F; Wang N; Feng S; Lin X; Yang F; Chen Y; Wei H; Li YX
    Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36410795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of CD36 in nonalcoholic fatty liver disease].
    Zhan Z; Ren H; Peng ML
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):953-956. PubMed ID: 29325301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis.
    Zhang L; Wang P; Shi M; Fang Z; Ji J; Liao X; Hu X; Chen F
    J Nutr Biochem; 2020 Jun; 80():108365. PubMed ID: 32217466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
    Wang X; Ren Q; Wu T; Guo Y; Liang Y; Liu S
    Mol Med Rep; 2014 Dec; 10(6):2917-23. PubMed ID: 25310357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway.
    Zhong S; Zhao L; Wang Y; Zhang C; Liu J; Wang P; Zhou W; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Antioxid Redox Signal; 2017 Aug; 27(4):201-214. PubMed ID: 27967209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P38γ modulates the lipid metabolism in non-alcoholic fatty liver disease by regulating the JAK-STAT signaling pathway.
    Yao Y; Luo ZP; Li HW; Wang SX; Wu YC; Hu Y; Hu S; Yang CC; Yang JF; Wang JP; Peng L; Chen F; Pan LX; Xu T
    FASEB J; 2023 Jan; 37(1):e22716. PubMed ID: 36527390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization.
    Cheng J; Liu C; Hu K; Greenberg A; Wu D; Ausman LM; McBurney MW; Wang XD
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2783-2790. PubMed ID: 28789977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
    Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
    J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring.
    Fu Q; North PE; Ke X; Huang YW; Fritz KA; Majnik AV; Lane RH
    J Nutr; 2021 Oct; 151(10):3102-3112. PubMed ID: 34486661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
    Enooku K; Tsutsumi T; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Nakagomi R; Minami T; Sato M; Uchino K; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Koike K
    J Gastroenterol; 2020 Feb; 55(2):227-243. PubMed ID: 31602526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
    Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.